About Spherotec
Spherotec is a Healthcare company based in Planegg (Germany) founded in 2006 by Barbara Mayer and Ilona Funke. Developing spheroid microtumor technology for use in drug development and therapy selection. The company has 3 employees. Its chief executive, as recorded, is Barbara Mayer. Spherotec offers products and services including Magnetic Beads, Rainbow Calibration, Sphero Beads, and Glutamine Assay Kit. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is SpheroTec GmbH.
Company details
Spherote, a spin-off of the Ludwig-Maximillians-Universität München. aiming to optimize oncological therapies through the use of the proprietary Späroid microtumor technology. Spherotec has developed an in vitro analysis method using multicellular spheroid technology. In contrast to conventional cell culture methods and mouse models, spheroid microtumor technology allows realistic functional testing of drugs. The multicellular, three-dimensionally growing spheroid systems have similar biological properties as the microtumors in the clinical situation. The following are the claimed advantages of using the spheroid system - differentiated tumor architecture; small multiplication rate of the cells; tumor heterogeneity; interaction of tumor cells with connective tissue and immune cell; high resistance to therapy. The manufacture of the spheroid systems is quality assured. It is standardized and reproducible according to ISO 9001: 2008 and GLP.
- Headquarters Planegg, Germany
- Employees 3
- Founders Barbara Mayer, Ilona Funke
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website spherotec.com
- Legal Name Spherotec Gmbh
- Latest Funding Round$54.46K (USD), Grant
Apr 2017
- InvestorsEuropean Union
& 1 more
- Employee Count3
Products & Services of Spherotec
Spherotec offers a comprehensive portfolio of products and services, including Magnetic Beads, Rainbow Calibration, Sphero Beads, and Glutamine Assay Kit.
Products for early identification of active ingredients in therapies
Tools for optimizing drug development processes
Beads used in glycan-protein associations for vaccine research
Colorimetric kit for drug profiling and methodologies
Funding Insights of Spherotec
- Total Rounds 2
- Last Round Grant — $54,456
- First Round $52,630
(Jan 2017)
- Investors Count 2
All 2 funding rounds of Spherotec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2017 | $54,456 | Grant | – | – | |
| Jan 2017 | $52,630 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Spherotec
Spherotec has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Spherotec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Spherotec
2 people are tracked at Spherotec (2 in leadership); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Barbara Mayer | Co-Founder & Co-CEO | Leadership |
Ilona Funke | Founder | Leadership |
Complete people profiles for Spherotec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Spherotec
3 dated milestones of Spherotec across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Spherotec is founded.
- Funding First funding round of $53K.
- Funding Latest funding round, Grant, of $54K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spherotec
Spherotec was founded in 2006 and raised its 1st funding round 11 years after it was founded.
Spherotec is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
Barbara Mayer is the CEO of Spherotec, as recorded in our data. They have also founded this company.
Spherotec has 3 employees.
Spherote, a spin-off of the Ludwig-Maximillians-Universität München. aiming to optimize oncological therapies through the use of the proprietary Späroid microtumor technology. Spherotec has developed an in vitro analysis method using multicellular spheroid technology. In contrast to conventional cell culture methods and mouse models, spheroid microtumor technology allows realistic functional testing of drugs. The multicellular, three-dimensionally growing spheroid systems have similar biological properties as the microtumors in the clinical situation. The following are the claimed advantages of using the spheroid system - differentiated tumor architecture; small multiplication rate of the cells; tumor heterogeneity; interaction of tumor cells with connective tissue and immune cell; high resistance to therapy. The manufacture of the spheroid systems is quality assured. It is standardized and reproducible according to ISO 9001: 2008 and GLP.
Spherotec offers Magnetic Beads, Rainbow Calibration, Sphero Beads, and Glutamine Assay Kit.
Spherotec has 2 investors. Key investors include European Union, and EIC Fund.
Spherotec operates through Spherotec Gmbh.